asa guidelines for glp 1 Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment on Br J Anaesth 2025; 135: 48–78 Do current fasting guidelines ensure

Description

The Trump administration announced Thursday that it has reached deals with Eli Lilly $LLY and Novo Nordisk to lower the prices of some of their popular GLP-1 weight loss drugs in exchange for partial Medicare coverage, which opens up new markets for both companies

The researchers noted that the effect appeared to be associated with mood-related reductions in eating, which aligns with appetite behavior patterns associated with emotional or compulsive eating

The most prevalent factors employers take into consideration for GLP-1 drug coverage for obesity care include: Obesity as a risk factor for chronic conditions and associated costs67% Drug shortages47% Impact/effectiveness of cost-control mechanisms47% Existing coverage through government programs40% Long-term costs33% Patient and prescriber demand33%